J. Greig

发表

Development of a T-cell Receptor Mimic Antibody against Wild-Type p53 for Cancer Immunotherapy.

B. Cornelissen, A. Banham, M. Cragg, 2017, Cancer research.

AAV8 Gene Therapy Rescues the Newborn Phenotype of a Mouse Model of Crigler-Najjar.

James M. Wilson, P. Bell, J. Greig, 2018, Human gene therapy.

Intramuscular administration of AAV overcomes pre-existing neutralizing antibodies in rhesus macaques.

James M. Wilson, R. Calcedo, R. Grant, 2016, Vaccine.

Muscle-directed AAV gene therapy rescues the maple syrup urine disease phenotype in a mouse model.

James M. Wilson, J. Greig, Melanie K. Smith, 2021, Molecular genetics and metabolism.

Adeno-associated viral gene therapy corrects a mouse model of argininosuccinic aciduria.

James M. Wilson, E. Buza, J. Greig, 2018, Molecular genetics and metabolism.

Lentivirus-mediated reprogramming of somatic cells in the absence of transgenic transcription factors.

C. von Kalle, G. Milligan, M. Houslay, 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

Engineering chimeric human and mouse major histocompatibility complex (MHC) class I tetramers for the production of T-cell receptor (TCR) mimic antibodies

A. Banham, Demin Li, Carol Bentley, 2017, PloS one.

Development of Therapeutic Anti-JAGGED1 Antibodies for Cancer Therapy

A. Harris, A. Banham, P. Handford, 2019, Molecular Cancer Therapeutics.

Nonclinical Pharmacology/Toxicology Study of AAV8.TBG.mLDLR and AAV8.TBG.hLDLR in a Mouse Model of Homozygous Familial Hypercholesterolemia.

D. Rader, James M. Wilson, Shu-Jen Chen, 2017, Human gene therapy. Clinical development.

Non-Clinical Study Examining AAV8.TBG.hLDLR Vector-Associated Toxicity in Chow-Fed Wild-Type and LDLR+/- Rhesus Macaques.

D. Rader, James M. Wilson, Shu-Jen Chen, 2017, Human gene therapy. Clinical development.

TBG . mLDLR and AAV 8 . TBG . hLDLR in a Mouse Model of Homozygous Familial Hypercholesterolemia

D. Rader, James M. Wilson, Shu-Jen Chen, 2017 .

Intranasal gene therapy to prevent infection by SARS-CoV-2 variants

Kevin B. Turner, James M. Wilson, Shu-Jen Chen, 2021, bioRxiv.

A Gene Therapy Approach to Improve Copper Metabolism and Prevent Liver Damage in a Mouse Model of Wilson Disease.

James M. Wilson, P. Bell, Yanqing Zhu, 2019, Human gene therapy. Clinical development.

Loss of transgene expression limits liver gene therapy in primates

Lili Wang, James M. Wilson, P. Bell, 2022, bioRxiv.

AAV8 Gene Therapy for Crigler-Najjar Syndrome in Macaques Elicited Transgene T Cell Responses That Are Resident to the Liver

M. Betts, James M. Wilson, R. Calcedo, 2018, Molecular therapy. Methods & clinical development.

Determining the Minimally Effective Dose of a Clinical Candidate Adeno-Associated Virus Vector in a Mouse Model of Hemophilia A

James M. Wilson, L. Kattenhorn, N. Schmidt, 2021, Human gene therapy.

Optimized Adeno-Associated Viral-Mediated Human Factor VIII Gene Therapy in Cynomolgus Macaques.

Lili Wang, James M. Wilson, S. Wadsworth, 2018, Human gene therapy.

Super-Treg: Toward a New Era of Adoptive Treg Therapy Enabled by Genetic Modifications

H. Volk, P. Reinke, I. Anegon, 2021, Frontiers in Immunology.

Adenovirus Serotype 5 Hexon Mediates Liver Gene Transfer

C. Napoli, D. Bhella, N. Rooijen, 2008, Cell.

Intramuscular Injection of AAV8 in Mice and Macaques Is Associated with Substantial Hepatic Targeting and Transgene Expression

James M. Wilson, Shu-Jen Chen, R. Grant, 2014, PloS one.

Targeted delivery of biological agents.

J. Greig, Jenny Greig, 2009 .

Dynamic Changes in Lung MicroRNA Profiles During the Development of Pulmonary Hypertension due to Chronic Hypoxia and Monocrotaline

R. Khanin, J. McClure, N. Morrell, 2010, Arteriosclerosis, thrombosis, and vascular biology.

Muscle‐directed gene therapy for hemophilia B with more efficient and less immunogenic AAV vectors

J. Wilson, P. Bell, J. Louboutin, 2011, Journal of thrombosis and haemostasis : JTH.

Characterization of Adeno-Associated Viral Vector-Mediated Human Factor VIII Gene Therapy in Hemophilia A Mice.

Lili Wang, James M. Wilson, K. Clark, 2017, Human gene therapy.

Impact of intravenous infusion time on AAV8 vector pharmacokinetics, safety, and liver transduction in cynomolgus macaques

James M. Wilson, L. Kattenhorn, P. Bell, 2016, Molecular therapy. Methods & clinical development.

Vascular-Targeting Antioxidant Therapy in a Model of Hypertension and Stroke

A. Dominiczak, R. Shirley, L. Work, 2010, Journal of cardiovascular pharmacology.

Lipid nanoparticle-encapsulated mRNA therapy corrects serum total bilirubin level in Crigler-Najjar syndrome mouse model

James M. Wilson, P. Martini, E. Buza, 2023, Molecular therapy. Methods & clinical development.

Determining the Minimally Effective Dose of a Clinical Candidate AAV Vector in a Mouse Model of Crigler-Najjar Syndrome

J. Gray, James M. Wilson, P. Bell, 2018, Molecular therapy. Methods & clinical development.

Intravenous immunoglobulin prevents peripheral liver transduction of intrathecally delivered AAV vectors

James M. Wilson, J. Chichester, P. Bell, 2022, Molecular therapy. Methods & clinical development.

Influence of coagulation factor x on in vitro and in vivo gene delivery by adenovirus (Ad) 5, Ad35, and chimeric Ad5/Ad35 vectors.

Jenny A Greig, Suzanne Mk Buckley, Simon N Waddington, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

Increasing the specificity of AAV-based gene editing through self-targeting and short promoter strategies.

James M. Wilson, J. Greig, Melanie K. Smith, 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors.

Hongjie Wang, R. Mcdonald, N. Van Rooijen, 2010, Blood.

ITR-Seq, a next-generation sequencing assay, identifies genome-wide DNA editing sites in vivo following adeno-associated viral vector-mediated genome editing

Jenny A. Greig, Lili Wang, James M. Wilson, 2020, BMC Genomics.